Johnson & Johnson (JNJ) stock
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$272.70−6.00 (-2.15%)
Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%
Johnson & Johnson market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Johnson & Johnson's market cap was $685.40B on Nov 11, 2026, against $501.81B a year earlier. Over the last 5 years it ranged from $351.12B to $685.40B, with a median of $436.08B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $685.40B | +36.6% |
| 2025 | Dec 31, 2025 | $501.88B | +42.9% |
| 2024 | Dec 31, 2024 | $351.12B | -14.1% |
| 2023 | Dec 29, 2023 | $408.86B | -13.2% |
| 2022 | Dec 30, 2022 | $471.12B | +3.1% |
| 2021 | Dec 31, 2021 | $457.17B | +8.8% |
| 2020 | Dec 31, 2020 | $420.15B | +6.8% |
| 2019 | Dec 31, 2019 | $393.35B | +11.6% |
| 2018 | Dec 31, 2018 | $352.40B | -8.3% |
| 2017 | Dec 29, 2017 | $384.21B | +19.3% |
| 2016 | Dec 30, 2016 | $322.12B | +11.1% |
| 2015 | Dec 31, 2015 | $289.86B | -3.5% |
| 2014 | Dec 31, 2014 | $300.23B | +14.3% |
| 2013 | Dec 31, 2013 | $262.60B | +34.3% |
| 2012 | Dec 31, 2012 | $195.57B | +6.9% |
| 2011 | Dec 30, 2011 | $182.89B | +5.8% |
| 2010 | Dec 31, 2010 | $172.86B | -3.8% |
| 2009 | Dec 31, 2009 | $179.77B | – |
See a number that looks wrong?